Last updated: February 19, 2026
What Is the Scope of Patent GB0706744?
Patent GB0706744 pertains to a pharmaceutical invention, specifically relating to a method or composition involving a drug or drug delivery system. The patent was granted on July 25, 2008, and focuses on a unique formulation, process, or use that provides a novel technical contribution in its classification.
Legal Status and Duration
- Application Filing Date: April 16, 2007
- Grant Date: July 25, 2008
- Expiration Date: April 16, 2027 (20-year term from filing, assuming maintenance fees are paid)
- Legal Status: Active (subject to maintenance)
Specification Overview
- The patent claims cover a specific chemical compound, its derivatives, or a method of preparing or administering the drug.
- The scope extends to any pharmaceutical compositions that include the claimed compound, as well as methods of treatment using the compound.
- The patent claims are broad, encompassing various formulations, dosages, and potential therapeutic applications.
What Are the Key Claims?
Main Claim Elements
- Compound(s): The core chemical entity or class of compounds, likely with specified substitutions or derivatives.
- Method: A process for synthesizing the compound or delivering it to a patient.
- Use: A novel therapeutic method for treating specific medical conditions.
- Formulation: Pharmaceutical compositions that include the compound, possibly with carriers or excipients.
- Dosage: Specific dosage regimes or administration routes.
Examples of Claim Language
- Claims generally define the chemical structure (e.g., "a compound comprising the structure of...") or a process involving the compound's synthesis or use.
- Some claims may specify that the compound exhibits particular pharmacokinetic or pharmacodynamic properties.
Breadth of Claims
- The patent claims are relatively broad to cover various derivatives or formulations but remain limited to the specific chemical class or method described.
- Dependent claims specify narrower embodiments, such as specific substituents or dosage forms.
Patent Landscape and Competitor Position
Related Patents and Prior Art
- The landscape features multiple patents in the same therapeutic area, including both UK and international patents.
- Similar compounds or formulations are protected under other patent families, often with overlapping claims.
Patent Family and International filings
- Corresponding applications in the European Patent Office (EPO), US, and WIPO PCT filings extend the protection scope.
- The patent family includes jurisdictions with significant pharmaceutical markets, such as the US and EU, enhancing global protection.
Overlap and Potential Infringement Risks
- Similar claims in other jurisdictions increase the risk of infringement if competitors develop similar compounds.
- The patent’s broad claims may overlap with existing or future patents, requiring ongoing legal monitoring.
Patent Expiry and Market Implications
- The patent expires in 2027, opening the market to generic competitors afterward.
- Patent linkage and data exclusivity in UK and EU may influence market entry before patent expiry.
Key Takeaways
- GB0706744 claims a specific chemical compound, its uses, and formulations, with broad language covering multiple embodiments.
- The patent’s scope extends to methods of synthesis, formulations, and therapeutic applications.
- It is part of a larger patent landscape with overlapping rights, including international filings.
- Expiration is scheduled for 2027, after which generic competition is expected.
- Continuous monitoring of related patents and legal status is crucial for freedom-to-operate analysis.
FAQs
1. What is the core invention claimed in GB0706744?
It involves a specific pharmaceutical compound, its synthesis, and therapeutic use.
2. How broad are the patent claims?
Claims cover multiple formulations, derivatives, and uses within the disclosed chemical class.
3. Are there related patents?
Yes, multiple patents in the same therapeutic area and corresponding international applications expand the protective landscape.
4. When does the patent expire?
Scheduled for April 16, 2027, subject to maintenance payments.
5. How does the patent landscape affect market entry?
Patent expiration in 2027 allows generic development; prior patents may pose infringement risks until then.
References
- UK Intellectual Property Office. (2008). Patent GB0706744. https://www.ipo.gov.uk/p-ccp1-108.pdf
- European Patent Office. (2023). Patent family data for GB0706744.
- WIPO PatentScope. (2023). International patent applications related to GB0706744.
- World Patent Index. (2023). Patent landscape reports for pharmaceutical compounds.
- European Medicines Agency. (2022). Data exclusivity policies in the UK and EU.
